News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cardiex.
RELATED STOCKHEAD STORIES
Health & Biotech
Blood Pressure Breakthrough: CardieX gets FDA green light for world-first vascular biometric monitor
Health & Biotech
ASX Health Stocks: CardieX jumps 16pc after FDA clearance; 3 other ASX biotechs to commence trials
News
CLOSING BELL: Iron ore price plunge leads the ASX lower, leaving REEs to rule the roost
Health & Biotech
CardieX Raises $4.5 million as it gears up for dual US listing as CONNEQT Pulse awaits FDA Clearance
News
CLOSING BELL: If everything could just stop blowing up for a while, that’d be great.
News
CLOSING BELL: RBA delivers Lowe voltage shock with ‘more now, and more to come’ interest rate call
News
LAST ORDERS: A quick-fire look back at a day that really should have gone better
Health & Biotech
CardieX pumped up with insto support for $4.33 million raise – announces additional purchase plan for shareholders
News
ASX Quarterlies: Companies shine amidst market volatility
Health & Biotech
ASX Health Stocks: Orthocell up 35pc after shaking on exclusive global patent deal
Health & Biotech
CardieX ratchets up commercialisation strategy with FDA lodgement for CONNEQT Pulse
News
Weekly Small Cap and IPO Wrap: In a pickle? Just buy Nordic Nickel
News
Closing Bell: Thank heavens for the earth, as miners and metals keep everything afloat
Health & Biotech
CardieX gets hearts racing as MST Access reaffirms value at 5x current share price
Health & Biotech
ASX Health Stocks: Imugene begins Phase 1 trial of its cancer-fighting virus
News
ASX Small Cap Lunch Wrap: Who’s competing for the ultimate title today?
Health & Biotech
